Back to Pharmacokinetics
Novartis

Pharmacokinetics

This course begins with a review of routes of administration, ADME (absorption, distribution, metabolism, & excretion), and the use of in vivo drug concentration-time data to determine key pharmacokinetic parameters, like volume of distribution, half-life and clearance.  The course then emphasizes in vitro assays that allow rapid prediction of ADME and PK properties for evaluation of new compounds.  The later stages of the course focus on how drug discovery teams study this PK/PD relationship, as well as dose size and frequency predictions which ultimately assist in selection of a compound for advancement into the clinic.   This course is suitable for life scientists, clinicians, and individuals from fields that support drug discovery (e.g., patents, finance, licensing, etc.) interested in learning more about the pharmaceutical/biotechnology sector. Advanced undergraduate coursework or practical familiarity/working knowledge in biological sciences and organic chemistry is recommended.

Status: Laboratory Research
Status: Pre-Clinical Development
IntermediateCourse12 hours

Featured reviews

OI

5.0Reviewed Jul 14, 2024

Amazing to-the-point course content, great citations to key articles and questions which are very helpful for permenance. I'm pleased as a medical doctor in drug research. Thanks for this course!

AP

5.0Reviewed Sep 7, 2024

Amazing course for people intending to pursue higher studies in the field of pharmacology

EK

4.0Reviewed Aug 4, 2024

Overall comprehensive basic content, clearly presented. Feedback on quizzes and assignments needs to be clearer and more informative in some cases.

KK

5.0Reviewed May 31, 2024

I enjoyed the entire specialization thanks to great bit sized lectures, additional readings, videos and exploratory exercises.

PV

5.0Reviewed Sep 5, 2024

Excellent at offering concepts of Pharmacokinetics

YD

5.0Reviewed Nov 3, 2024

very good guide entire course gives great insight on industry

All reviews

Showing: 16 of 16

Aditya Pawar
5.0
Reviewed Sep 8, 2024
Yosan Daniel
5.0
Reviewed Nov 4, 2024
Elaina Kenyon
4.0
Reviewed Aug 5, 2024
Nicholas Dubicki
5.0
Reviewed Sep 3, 2024
Oğuz Can Işık
5.0
Reviewed Jul 15, 2024
Katarína Kukanová
5.0
Reviewed Jun 1, 2024
Норкина Юлия Петровна
5.0
Reviewed Nov 28, 2024
Panduranga Rao Varada
5.0
Reviewed Sep 6, 2024
Alexandra Rizzitelli
5.0
Reviewed Oct 6, 2024
Viveykitha
5.0
Reviewed May 10, 2025
Rahul Mishra
5.0
Reviewed Jun 22, 2025
SHREYA S
5.0
Reviewed Sep 21, 2024
KS Pan
5.0
Reviewed Aug 20, 2025
SOURISH NANDA
5.0
Reviewed Dec 22, 2024
Paolo Cappella
5.0
Reviewed Apr 4, 2025
Tasneem Ahmed
5.0
Reviewed May 29, 2024